These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1444701)

  • 1. Improved survival in mice with diet-induced pancreatitis treated with new potent protease inhibitor, E-3123 and a broad spectrum antibiotic, cefmetazole.
    Hirano T; Manabe T; Ohshio G; Nio Y
    Nihon Geka Hokan; 1992 May; 61(3):213-23. PubMed ID: 1444701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy of a cephalosporin, Shiomarin and a new potent protease inhibitor, E3123 in rat taurocholate-induced pancreatitis.
    Hirano T; Manabe T
    Nihon Geka Hokan; 1992 Nov; 61(6):423-32. PubMed ID: 1306980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of combined therapy with a protease inhibitor, ONO 3307, and a xanthine oxidase inhibitor, allopurinol on temporary ischaemic model of pancreatitis in rats.
    Hirano T; Manabe T; Ohshio G; Nio Y
    Nihon Geka Hokan; 1992 May; 61(3):224-33. PubMed ID: 1444702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of protease inhibitor FUT-175 on acute hemorrhagic pancreatitis in mice.
    Suzuki M; Isaji S; Stanten R; Frey CF; Ruebner B
    Int J Pancreatol; 1992 Feb; 11(1):59-65. PubMed ID: 1374785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
    Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
    Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats.
    Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T
    Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effect of a cephalosporin, Shiomarin, plus a new potent protease inhibitor, E3123, on rat taurocholate-induced pancreatitis.
    Hirano T; Manabe T; Imanishi K; Tobe T
    J Gastroenterol Hepatol; 1993; 8(1):52-9. PubMed ID: 8439663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the cholecystokinin receptor antagonist L-364,718 on pancreatitis induced by a deficient in choline and supplemented with ethionine (CDE) diet in the rat.
    Manso MA; Rodriguez AI; Garcia-Montero AC; De Dios I
    Arch Physiol Biochem; 1995 Aug; 103(4):410-5. PubMed ID: 8548474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone attenuates local and systemic inflammatory responses to ameliorate diet-induced severe necrotic pancreatitis in mice: it may provide a new therapy for acute pancreatitis.
    Yamaguchi I; Hamada K; Yoshida M; Isayama H; Kanazashi S; Takeuchi K
    J Pharmacol Exp Ther; 2009 Jan; 328(1):256-62. PubMed ID: 18832108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
    Sakai Y; Masamune A; Satoh A; Nishihira J; Yamagiwa T; Shimosegawa T
    Gastroenterology; 2003 Mar; 124(3):725-36. PubMed ID: 12612911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123.
    Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y
    Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis.
    Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T
    Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
    Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
    Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity and subcellular distribution of lysosomal enzymes in acute pancreatitis induced by CDE diet in mice].
    Guillaumes S; Blanco I; Villanueva A; Sans MD; Clavé P; Chabás A; Farré A; Lluís F
    Gastroenterol Hepatol; 1996 Mar; 19(3):146-52. PubMed ID: 8991657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate].
    Hirano T; Manabe T; Tobe T
    Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of PGE2 on diet-induced acute pancreatitis in mice.
    Manabe T; Steer ML
    Gastroenterology; 1980 Apr; 78(4):777-81. PubMed ID: 6153372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of R-102444 and its active metabolite R-96544, selective 5-HT2A receptor antagonists, on experimental acute and chronic pancreatitis: Additional evidence for possible involvement of 5-HT2A receptors in the development of experimental pancreatitis.
    Ogawa T; Sugidachi A; Tanaka N; Fujimoto K; Fukushige J; Tani Y; Asai F
    Eur J Pharmacol; 2005 Oct; 521(1-3):156-63. PubMed ID: 16183055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123.
    Hirano T; Manabe T
    Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished lung injury with vascular adhesion molecule-1 blockade in choline-deficient ethionine diet-induced pancreatitis.
    Callicutt CS; Sabek O; Fukatsu K; Lundberg AH; Gaber L; Wilcox H; Kotb M; Gaber AO
    Surgery; 2003 Feb; 133(2):186-96. PubMed ID: 12605180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis.
    Hirano T; Manabe T
    Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.